Cargando…

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins

Detalles Bibliográficos
Autores principales:	Amini, Arya, Karam, Sana D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363014/ https://www.ncbi.nlm.nih.gov/pubmed/30774757 http://dx.doi.org/10.18632/oncotarget.26594

Ejemplares similares

The Benefit of Zinc Sulfate in Oropharyngeal Mucositis during Hyperfractionated Accelerated Concomitant Boost Radiotherapy with Concurrent Cisplatin for Advanced-Stage Oropharyngeal and Hypopharyngeal Cancers
por: Anandhi, P, et al.
Publicado: (2020)

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
por: Price, James M., et al.
Publicado: (2022)

Oral systemic therapy: Not all “win-win”
por: Bhattacharyya, G. S.
Publicado: (2010)

Minneapolis Wins
Publicado: (1902)

Wean to Win
por: Havaldar, Amarja Ashok, et al.
Publicado: (2023)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
por: HASEGAWA, MASAHIRO, et al.
Publicado: (2014)

Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results
por: Kovács, A F
Publicado: (2004)

Are we winning the fight?
por: Damle, S. G.
Publicado: (2014)

Who dares, wins?
por: Kim, Tae-Il
Publicado: (2016)

Buffalo Wins for 1896
Publicado: (1896)

Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
por: Chau, Brittney, et al.
Publicado: (2019)

The Board Wins
Publicado: (1910)

A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
por: Nanda, R., et al.
Publicado: (2019)

COVID-19: losing battles or winning the war?
por: Reperant, Leslie A., et al.
Publicado: (2020)

Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?
por: LeVasseur, N, et al.
Publicado: (2017)

An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites
por: Pharaon, Rebecca, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review
por: Amini, Arya, et al.
Publicado: (2014)

Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy
por: Alexidis, Petros, et al.
Publicado: (2023)

Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy
por: Zhang, Ya-Ni, et al.
Publicado: (2023)

Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes
por: Soliman, Ola, et al.
Publicado: (2023)

Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review
por: Hui, Caressa, et al.
Publicado: (2021)

Population-level and individual-level explainers for propensity score matching in observational studies
por: Ghosh, Debashis, et al.
Publicado: (2022)

BMC Ecology image competition: the winning images
por: Harold, Simon, et al.
Publicado: (2013)

Immunomodulation and COVID-19: Is There a Winning Combination?
por: Samavedam, Srinivas
Publicado: (2020)

#EchoFirst Wins Gold, Silver, and Bronze
por: Sorrell, Vincent L.
Publicado: (2022)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zeng, Zhen, et al.
Publicado: (2018)

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
por: Hu, Ming-Hung, et al.
Publicado: (2014)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2016)

Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
por: Roskies, M., et al.
Publicado: (2016)

China and the European Union in Africa: win–win-lose or win–win-win?
por: Che, Dewei, et al.
Publicado: (2023)

Monocomponent chemoembolization in oral and oropharyngeal cancer using an aqueous crystal suspension of cisplatin
por: Kovács, A F, et al.
Publicado: (2002)

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
por: Wilkowski, R, et al.
Publicado: (2009)

Irradiation of HPV-associated oropharyngeal cancer: Is less really more?
por: Mallory, Matthew, et al.
Publicado: (2017)

HPV in non-oropharyngeal head and neck cancer: does it matter?
por: Schmitt, Nicole C.
Publicado: (2020)

BMC ecology image competition 2018: the winning images
por: Cuff, Alison L., et al.
Publicado: (2019)

PH WINS as a Tool for Growth: Strengths and Weaknesses
por: Bridger, Colleen
Publicado: (2019)

Anemia: winning elbow room in the field of hematology and hemotherapy
por: Cançado, Rodolfo Delfini
Publicado: (2012)

BMC Ecology Image Competition 2015: the winning images
por: Potenski, Catherine J, et al.
Publicado: (2015)

BMC Ecology image competition 2014: the winning images
por: Harold, Simon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tntgd0ebsbaqkeam2crt8eilv7